SAN
83.26
-2%↓
SHL.DE
43.27
-0.28%↓
ARGX
782.4
+1.64%↑
PHIA
23.35
+0.09%↑
ONC.US
325.82
+1%↑
SAN
83.26
-2%↓
SHL.DE
43.27
-0.28%↓
ARGX
782.4
+1.64%↑
PHIA
23.35
+0.09%↑
ONC.US
325.82
+1%↑
SAN
83.26
-2%↓
SHL.DE
43.27
-0.28%↓
ARGX
782.4
+1.64%↑
PHIA
23.35
+0.09%↑
ONC.US
325.82
+1%↑
SAN
83.26
-2%↓
SHL.DE
43.27
-0.28%↓
ARGX
782.4
+1.64%↑
PHIA
23.35
+0.09%↑
ONC.US
325.82
+1%↑
SAN
83.26
-2%↓
SHL.DE
43.27
-0.28%↓
ARGX
782.4
+1.64%↑
PHIA
23.35
+0.09%↑
ONC.US
325.82
+1%↑
24 val.
Dabar
Min
119.1
Max
120.5
Pajamos | 250M 902M |
|---|---|
Pardavimai | 63M 5.3B |
Pelnas, tenkantis vienai akcijai | 2.07 |
Dividendų pajamingumas | 1.34 |
Pelno marža | 16.961 |
Rekomendacijos | Pirkti |
|---|---|
12 mėnesių prognozė | +16.51% upside |
Dividendų pajamingumas Sektoriaus vid. | 1.34% 2.29% |
|---|
Rinkos kapitalizacija | 98B |
|---|---|
Ankstesnė atidarymo kaina | 120.3 |
Ankstesnė uždarymo kaina | 119.3 |
By Acuity
10%
90%
7 / 374 reitingas Healthcare
By Trading Central
Pasitikėjimas
Strong Bearish Evidence
121.15 / 123.55 Palaikymas ir pasipriešinimas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
2025-11-13 13:40; UTC
Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update
DJ
Skaityti
2025-11-13 06:24; UTC
Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units
DJ
Skaityti
2025-10-01 08:54; UTC
Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site
DJ
Skaityti
2025-11-13 07:57; UTC
Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA Says Guidance Midpoint Remains Unchanged
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA Sees 2025 Organic Sales Growth of Around 3%
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA 3Q After-Tax Profit EUR898M
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA Narrows 2025 View
DJ
Skaityti
2025-11-13 06:00; UTC
Analysts Saw Merck KGaA 3Q Net Sales at EUR5.23B
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.67B
DJ
Skaityti
2025-11-13 06:00; UTC
Analysts Saw Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.56B
DJ
Skaityti
2025-11-13 06:00; UTC
Merck KGaA 3Q Sales EUR5.32B
DJ
Skaityti
2025-11-06 21:52; UTC
Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED
DJ
Skaityti
2025-11-06 21:51; UTC
Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany
DJ
Skaityti
2025-10-16 08:34; UTC
Merck KGaA's Cost Cutting Likely Led to Profitability Target Raise -- Market Talk
DJ
Skaityti
2025-10-15 12:08; UTC
Merck KGaA Didn't Disclose Financial Details
DJ
Skaityti
2025-10-15 12:07; UTC
Merck KGaA: JSR's Amsphere Protein A Resin Tech Complements Existing Biologics Portfolio
DJ
Skaityti
2025-10-15 12:07; UTC
Merck KGaA: Unit is Based in Belgium, Has 50+ Employees
DJ
Skaityti
2025-10-15 12:06; UTC
Merck KGaA: Deal Will Strengthen Position in Bioprocessing Market
DJ
Skaityti
2025-10-15 12:05; UTC
Merck KGaA: Definitive Agreement Signed Today
DJ
Skaityti
2025-10-15 12:05; UTC
Merck KGaA: Transaction Expected to Close by End of 2Q 2026
DJ
Skaityti
2025-10-15 12:04; UTC
Merck KGaA to Buy Chromatography Business JSR Life Sciences
DJ
Skaityti
2025-10-15 12:03; UTC
Merck KGaA to Buy Chromatography Business of JSR Life Sciences
DJ
Skaityti
2025-08-07 08:04; UTC
Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk
DJ
Skaityti
Kainos pokytis
By TipRanks
12 mėnesių prognozė
Vidutinis 140.57 EUR 16.51%
Aukščiausias 182 EUR
Žemiausias 105 EUR
Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Merck KGaA kainas – Dist per pastaruosius 3 mėnesius.
By TipRanks
Pirkti
8 ratings
5
Pirkti
2
Laikyti
1
Parduoti
Remiantis 8 analitikų, pateikusių Merck KGaA akcijų reitingus – Dist per pastaruosius 3 mėnesius.
By Trading Central
Trumpalaikis periodas
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Vidutinės trukmės periodas
Neutral Evidence
The bullish and bearish events are balanced.
Ilgalaikis periodas
Bearish Evidence
All events are bearish.
By Acuity
Naujienos nuotaikos
Labai stiprus bulių rinkos įrodymas
Svyravimai
Žemiau vidurkio
Naujienų apimtis (RCV)
Žemiau vidurkio
Pardavimo ir administravimo išlaidos
Veiklos sąnaudos
Ikimokestinis pelnas
Pardavimai
Pardavimo savikaina
Bendrasis pelnas iš pardavimo
Skolų palūkanų išlaidos
EBITDA
Veiklos pelnas
$